Systems and methods for optimizing medical care through data monitoring and feedback treatment
Inventors
Baronov, Dimitar V. • Butler, Evan J. • Lock, Jesse M.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-12763203-B2
Publication Date
2026-10-13
Expiration Date
Abstract
Systems, methods, and computer-readable media for providing a decision support solution to medical professionals to optimize medical care through data monitoring and feedback treatment are provided herein. In another embodiment, a computer-implemented method for modeling patient outcomes resulting from treatment in a specific medical area includes receiving patient-specific data associated with a patient, determining a plurality of possible patient states under which the patient can be categorized, a current patient state under which the patient can be categorized and determining probabilities of the patient transitioning from any of the possible patient states to every other possible patient state.
Core Innovation
The invention describes an event-driven medical decision-support system that uses patient-specific data, including data from a blood oximeter, to determine physiological variables and classify a patient into a clinical state. It defines states using boundaries for DO₂ and Qp/Qs, determines the patient’s current state, and sends a signal to a treatment device to administer a treatment known to address that state. The summary also describes calculating state-transition probabilities and recommending or automatically implementing treatment.
The provided partial content does not explicitly describe the problem being solved in the background section. It describes a post-operative hypoplastic left heart syndrome embodiment in which clinical states use DO₂ and Qp/Qs boundaries, and state-specific treatments include chronotropic medication and vasodilation medication. It also describes a hemorrhagic-trauma embodiment that models cumulative oxygen deficit and uses simulations to assess fluid-infusion and hospital-triage options.
Claims Coverage
The claim coverage encompasses three inventive features across independent claims 1, 4, and 7, directed to a system, a method, and a non-transitory computer-readable medium for event-driven patient monitoring and treatment.
Patient monitoring and treatment system
Claim 1 covers a computer processor and memory configured to receive patient-specific data that includes blood oximeter data, determine physiological variables including oxygen saturation, define clinical patient states using DO₂ and Qp/Qs boundaries, determine the patient’s current state, and signal a treatment device to administer a treatment known to address that state. The claim specifies a DO₂ boundary of 25 ml O₂/min/kg; dependent claims further specify a Qp/Qs threshold of 1.5 and state-associated medication types.
Computer-based patient monitoring and treatment method
Claim 4 covers receiving patient-specific data including blood oximeter data, determining physiological variables, defining clinical patient states using DO₂ and Qp/Qs boundaries, determining the current state, and sending a signal to a treatment device to administer a treatment known to address that state. The claim specifies a DO₂ boundary of 25 ml O₂/min/kg; dependent claims further specify a Qp/Qs threshold of 1.5 and state-associated medication types.
Computer-readable medium for patient monitoring and treatment
Claim 7 covers a non-transitory computer-readable medium with instructions that cause a computer to receive patient-specific data from sensors including a blood oximeter, determine physiological variables including oxygen saturation, define clinical patient states using DO₂ and Qp/Qs boundaries, determine the current state, and signal a treatment device to administer a treatment known to address that state. The claim specifies a DO₂ boundary of 25 ml O₂/min/kg; dependent claims further specify a Qp/Qs threshold of 1.5 and state-associated medication types.
The independent claims cover three forms of the same approach: a system, a method, and a computer-readable medium. Each uses patient-specific data to determine a clinical state defined by DO₂ and Qp/Qs boundaries and signals a treatment device to administer a treatment for that state.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Post-operative hypoplastic left heart syndrome: the described embodiment classifies clinical states using DO₂ and Qp/Qs boundaries and identifies state-specific treatments, including chronotropic medication and vasodilation medication.
Hemorrhagic trauma: the described embodiment models cumulative oxygen deficit and uses simulations to assess fluid-infusion and hospital-triage options.
Interested in licensing this patent?